Total Payments
$150,413
2024 Payments
$17,747
Companies
44
Transactions
551
Medicare Patients
8,373
Medicare Billing
$558,328
Payment Breakdown by Category
Other$104,594 (69.5%)
Travel$37,448 (24.9%)
Food & Beverage$8,017 (5.3%)
Education$353.94 (0.2%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $104,594 | 41 | 69.5% |
| Travel and Lodging | $37,448 | 76 | 24.9% |
| Food and Beverage | $8,017 | 430 | 5.3% |
| Education | $353.94 | 4 | 0.2% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Merck Sharp & Dohme LLC | $99,976 | 115 | $0 (2024) |
| Esperion Therapeutics, Inc. | $18,150 | 20 | $0 (2022) |
| Novartis Pharmaceuticals Corporation | $15,492 | 74 | $0 (2024) |
| AstraZeneca Pharmaceuticals LP | $11,083 | 48 | $0 (2024) |
| Abbott Laboratories | $1,043 | 35 | $0 (2024) |
| Amgen Inc. | $771.24 | 57 | $0 (2023) |
| Terumo Medical Corporation | $700.04 | 8 | $0 (2019) |
| Janssen Pharmaceuticals, Inc | $490.15 | 42 | $0 (2022) |
| ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | $299.44 | 23 | $0 (2023) |
| Chiesi USA, Inc. | $283.22 | 20 | $0 (2022) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $17,747 | 30 | Merck Sharp & Dohme LLC ($17,568) |
| 2023 | $69,708 | 95 | Merck Sharp & Dohme LLC ($69,220) |
| 2022 | $14,114 | 56 | Merck Sharp & Dohme LLC ($13,111) |
| 2021 | $21,126 | 71 | Esperion Therapeutics, Inc. ($18,138) |
| 2020 | $8,540 | 45 | AstraZeneca Pharmaceuticals LP ($7,736) |
| 2019 | $1,562 | 75 | Terumo Medical Corporation ($700.04) |
| 2018 | $1,203 | 73 | AstraZeneca Pharmaceuticals LP ($246.58) |
| 2017 | $16,414 | 106 | Novartis Pharmaceuticals Corporation ($14,926) |
All Payment Transactions
551 individual payment records from CMS Open Payments — Page 1 of 23
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 07/23/2024 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $24.76 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 07/11/2024 | Abbott Laboratories | THORATEC HEARTMATE 3 LVAS IMPLANT KIT (Device) | Food and Beverage | In-kind items and services | $13.14 | General |
| Category: Heart Failure | ||||||
| 06/12/2024 | Merck Sharp & Dohme LLC | VERQUVO (Drug), VERQUVO | Food and Beverage | In-kind items and services | $16.23 | General |
| Category: CARDIOVASCULAR | ||||||
| 06/11/2024 | Bayer Healthcare Pharmaceuticals Inc. | Kerendia (Drug) | Food and Beverage | In-kind items and services | $15.94 | General |
| Category: Cardio-renal | ||||||
| 05/30/2024 | Lexicon Pharmaceuticals, Inc. | — | Food and Beverage | In-kind items and services | $16.19 | General |
| 05/15/2024 | PFIZER INC. | VYNDAQEL (Drug) | Food and Beverage | In-kind items and services | $21.91 | General |
| Category: CARDIOVASCULAR | ||||||
| 05/13/2024 | Novartis Pharmaceuticals Corporation | ENTRESTO (Drug) | Food and Beverage | In-kind items and services | $15.34 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 05/06/2024 | Alnylam Pharmaceuticals Inc. | ONPATTRO (Drug) | Food and Beverage | In-kind items and services | $20.86 | General |
| Category: Genetic Disease | ||||||
| 04/30/2024 | Merck Sharp & Dohme LLC | VERQUVO (Drug), VERQUVO | Food and Beverage | In-kind items and services | $21.24 | General |
| Category: CARDIOVASCULAR | ||||||
| 04/22/2024 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $16.82 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 04/12/2024 | Merck Sharp & Dohme LLC | VERQUVO (Drug), VERQUVO | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $3,185.00 | General |
| Category: CARDIOVASCULAR | ||||||
| 04/05/2024 | Merck Sharp & Dohme LLC | VERQUVO (Drug), VERQUVO | Travel and Lodging | Cash or cash equivalent | $150.00 | General |
| Category: CARDIOVASCULAR | ||||||
| 04/04/2024 | Merck Sharp & Dohme LLC | VERQUVO (Drug), VERQUVO | Travel and Lodging | In-kind items and services | $1,198.17 | General |
| Category: CARDIOVASCULAR | ||||||
| 04/04/2024 | Merck Sharp & Dohme LLC | VERQUVO (Drug), VERQUVO | Travel and Lodging | In-kind items and services | $1,193.13 | General |
| Category: CARDIOVASCULAR | ||||||
| 04/04/2024 | Merck Sharp & Dohme LLC | VERQUVO (Drug), VERQUVO | Food and Beverage | In-kind items and services | $17.81 | General |
| Category: CARDIOVASCULAR | ||||||
| 03/25/2024 | Novartis Pharmaceuticals Corporation | ENTRESTO (Drug) | Food and Beverage | In-kind items and services | $16.61 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 03/19/2024 | Merck Sharp & Dohme LLC | VERQUVO (Drug), VERQUVO | Food and Beverage | In-kind items and services | $19.29 | General |
| Category: CARDIOVASCULAR | ||||||
| 03/06/2024 | Merck Sharp & Dohme LLC | VERQUVO (Drug), VERQUVO | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $3,185.00 | General |
| Category: CARDIOVASCULAR | ||||||
| 02/22/2024 | Merck Sharp & Dohme LLC | VERQUVO (Drug), VERQUVO | Travel and Lodging | Cash or cash equivalent | $150.00 | General |
| Category: CARDIOVASCULAR | ||||||
| 02/21/2024 | Merck Sharp & Dohme LLC | VERQUVO (Drug), VERQUVO | Travel and Lodging | In-kind items and services | $1,095.81 | General |
| Category: CARDIOVASCULAR | ||||||
| 02/21/2024 | Merck Sharp & Dohme LLC | VERQUVO (Drug), VERQUVO | Travel and Lodging | In-kind items and services | $1,078.73 | General |
| Category: CARDIOVASCULAR | ||||||
| 02/21/2024 | Merck Sharp & Dohme LLC | VERQUVO (Drug), VERQUVO | Travel and Lodging | In-kind items and services | $455.10 | General |
| Category: CARDIOVASCULAR | ||||||
| 02/21/2024 | Merck Sharp & Dohme LLC | VERQUVO (Drug), VERQUVO | Food and Beverage | In-kind items and services | $121.79 | General |
| Category: CARDIOVASCULAR | ||||||
| 01/31/2024 | Merck Sharp & Dohme LLC | VERQUVO (Drug), VERQUVO | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $3,185.00 | General |
| Category: CARDIOVASCULAR | ||||||
| 01/31/2024 | Novartis Pharmaceuticals Corporation | ENTRESTO (Drug) | Food and Beverage | In-kind items and services | $17.96 | General |
| Category: Cardiology/Vascular Diseases | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 5 | 176 | 299 | $75,526 | $28,066 |
| 2022 | 22 | 1,872 | 2,755 | $411,709 | $112,940 |
| 2021 | 29 | 2,938 | 4,092 | $576,877 | $196,996 |
| 2020 | 27 | 3,387 | 4,508 | $614,805 | $220,326 |
Total Patients
8,373
Total Services
11,654
Medicare Billing
$558,328
Procedure Codes
87
All Medicare Procedures & Services
87 procedure records from CMS Medicare Utilization — Page 1 of 4
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 58 | 134 | $32,562 | $12,517 | 38.4% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2023 | 57 | 88 | $30,184 | $11,443 | 37.9% |
| 99205 | New patient office or other outpatient visit, 60-74 minutes | Office | 2023 | 13 | 13 | $5,473 | $2,002 | 36.6% |
| 93306 | Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | Office | 2023 | 11 | 11 | $5,346 | $1,585 | 29.7% |
| 93000 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | Office | 2023 | 37 | 53 | $1,961 | $517.92 | 26.4% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 516 | 612 | $126,207 | $45,529 | 36.1% |
| 93306 | Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | Office | 2022 | 193 | 194 | $92,388 | $22,193 | 24.0% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2022 | 34 | 39 | $11,417 | $4,703 | 41.2% |
| 93294 | Evaluation of single, dual, multiple lead or leadless pacemaker system, remote up to 90 days | Office | 2022 | 70 | 213 | $12,567 | $4,210 | 33.5% |
| 99232 | Follow-up hospital inpatient care per day, typically 25 minutes | Facility | 2022 | 33 | 76 | $10,564 | $4,194 | 39.7% |
| 93296 | Evaluation of single, dual, multiple lead or leadless pacemaker system or implantable defibrillator system, remote up to 90 days | Office | 2022 | 93 | 284 | $12,993 | $4,035 | 31.1% |
| G2066 | Interrogation device evaluation(s), (remote) up to 30 days; implantable cardiovascular physiologic monitor system, implantable loop recorder system, or subcutaneous cardiac rhythm monitor system, remote data acquisition(s), receipt of transmissions and tec | Office | 2022 | 28 | 160 | $68,480 | $3,404 | 5.0% |
| 99222 | Initial hospital inpatient care per day, typically 50 minutes | Facility | 2022 | 29 | 30 | $7,860 | $3,033 | 38.6% |
| 93306 | Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | Facility | 2022 | 59 | 59 | $10,030 | $3,002 | 29.9% |
| 93458 | Insertion of tube in left lower heart chamber and coronary artery for diagnosis with review by radiologist | Facility | 2022 | 14 | 14 | $8,120 | $2,968 | 36.5% |
| 93297 | Evaluation of implantable heart and blood vessel monitoring system, remote up to 30 days | Office | 2022 | 22 | 128 | $6,528 | $2,337 | 35.8% |
| 78452 | Nuclear medicine studies of heart muscle at rest and with stress and spect | Facility | 2022 | 42 | 42 | $7,140 | $2,322 | 32.5% |
| 93000 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | Office | 2022 | 223 | 264 | $9,768 | $2,194 | 22.5% |
| 93010 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report only | Facility | 2022 | 319 | 387 | $7,740 | $2,158 | 27.9% |
| 93280 | Programming of dual lead pacemaker system | Office | 2022 | 35 | 39 | $4,462 | $2,092 | 46.9% |
| 93295 | Evaluation of single, dual, or multiple lead implantable defibrillator system, remote up to 90 days | Office | 2022 | 23 | 73 | $6,972 | $1,827 | 26.2% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2022 | 12 | 12 | $3,720 | $1,334 | 35.9% |
| 93018 | Exercise or drug-induced heart stress test with electrocardiogram (ecg) with review by physician | Facility | 2022 | 47 | 47 | $1,504 | $487.14 | 32.4% |
| 93227 | Electrocardiogram (ecg) 2-day continuous with review by health care professional | Office | 2022 | 19 | 19 | $1,083 | $261.24 | 24.1% |
| 93225 | Electrocardiogram (ecg) 2-day continuous | Office | 2022 | 18 | 18 | $1,224 | $224.33 | 18.3% |
About Dr. Prabodh Mehta, M.D
Dr. Prabodh Mehta, M.D is a Cardiovascular Disease healthcare provider based in Elizabethtown, Kentucky. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 08/12/2005. The National Provider Identifier (NPI) number assigned to this provider is 1982606604.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Prabodh Mehta, M.D has received a total of $150,413 in payments from pharmaceutical and medical device companies, with $17,747 received in 2024. These payments were reported across 551 transactions from 44 companies. The most common payment nature is "Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program" ($104,594).
As a Medicare-enrolled provider, Mehta has provided services to 8,373 Medicare beneficiaries, totaling 11,654 services with total Medicare billing of $558,328. Data is available for 4 years (2020–2023), covering 87 distinct procedure/service records.
Ad
Practice Information
- Specialty Cardiovascular Disease
- Location Elizabethtown, KY
- Active Since 08/12/2005
- Last Updated 09/15/2016
- Taxonomy Code 207RC0000X
- Entity Type Individual
- NPI Number 1982606604
Products in Payments
- VERQUVO (Drug) $99,976
- NEXLIZET (Drug) $15,742
- ENTRESTO (Drug) $15,444
- FARXIGA (Drug) $10,273
- NEXLETOL (Drug) $2,407
- Optitorque (Device) $681.50
- BRILINTA (Drug) $644.81
- Corlanor (Drug) $538.67
- XARELTO (Drug) $490.15
- Xience V coronary stent system (Device) $345.44
- PCI Optimization (Device) $306.51
- LifeVest (Device) $299.44
- Repatha (Biological) $217.47
- Optis Coronary Imaging System (Device) $190.23
- KENGREAL (Drug) $178.85
- ELIQUIS (Drug) $150.31
- General - Vascular Intervention (Device) $142.72
- Vascepa (Drug) $126.29
- NORTHERA (Drug) $109.82
- VYNDAQEL (Drug) $108.65
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Cardiovascular Disease Doctors in Elizabethtown
Dr. Krishnan Challappa, M.d, M.D
Cardiovascular Disease — Payments: $16,025
Cardiovascular Disease $16,025
John Holt, M.d, M.D
Cardiovascular Disease — Payments: $9,069
Cardiovascular Disease $9,069
Dr. Scott Monnin, M.d, M.D
Cardiovascular Disease — Payments: $9,067
Cardiovascular Disease $9,067
Mohammad Gayasaddin, Md, MD
Cardiovascular Disease — Payments: $230.02
Cardiovascular Disease $230.02